Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Stock Score, Valuation & Financial Research

Drugs Made In America Acquisition Corp. Ordinary Shares is in the Financial Services sector and Shell Companies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares does not currently have a complete Wall Street Score. The stored market price is USD 10.80. These figures are a research snapshot, not a buy or sell recommendation.

What Drugs Made In America Acquisition Corp. Ordinary Shares does

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Drugs Made In America Acquisition Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company does not currently have any operations or generate any revenue, and its business model is focused on identifying and completing an initial business combination.

Products and services

  • The company is a shell company with no commercial operations, products, or services; its primary activity is the search for a target company to acquire.

Business risks and research considerations

  • The company is a blank check company with no operating history and no revenues, and there is no assurance that it will be able to successfully effect a business combination. Source
  • The company may be unable to complete a business combination within the required time period, which would require it to liquidate. Source

Sources: Company research source

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

DMAA financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 10.80
Market capitalization:
262.19M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD 6.09M
Free cash flow:
USD -539.19K
Cash:
USD 20.28K
Total debt:
USD 950K
EPS:
USD 0.20
P/E ratio:
55.0x

What stands out

  • Free cash flow is USD -539.19K, negative for the stored period.
  • The balance sheet shows USD 20.28K of cash versus USD 950K of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a limited financial history warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Debt exceeds cash by USD 929.72K using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for DMAA

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can DMAA fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • Is DMAA's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What does the current limited financial history warning mean for the reliability or interpretation of DMAA's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 55% of the scoring inputs required for this public page are currently available.

How to research DMAA

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.